Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
about
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yesAlbumin-bound paclitaxel in solid tumors: clinical development and future directionsnab-paclitaxel for the management of patients with advanced non-small-cell lung cancer.Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel.Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer.Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent.Chemotherapy in Metastatic NSCLC - New Regimens (Pemetrexed, Nab-Paclitaxel)Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer.Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review.Ramucirumab for the treatment of advanced or metastatic non-small cell lung cancer.nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.Taxane-Induced Peripheral Neurotoxicity.
P2860
Q26766180-6364768A-0ED5-48BC-9CA8-F11F59E6272AQ26798674-1F55CEBF-7B5E-4CD2-9E9C-6F0F5598929DQ33412928-D0DA2BC7-8292-423A-8896-9E6AC21D52DAQ33423320-96D4B3F4-D37F-48AD-B21B-BB5150977656Q33427359-AA05EE1C-F6BA-4A3C-8911-9622887180E7Q37119741-4A58F3C1-6261-4187-AFB7-5215D9585CA2Q38237655-C6318CA8-7657-47BF-8ECA-28886C92E1F1Q38258744-EC291DF6-33A7-49A0-BAAC-31CD51DB691CQ38697158-C8671460-E874-4300-B843-03E0B66A6041Q38847914-7F042FE2-61CF-4864-A070-58C29FF3950BQ38853323-295BCE30-2FCB-4DC4-84BA-1AFBE9B67C1DQ38979788-2A54E65C-A1FE-4269-B282-61A425F3275DQ44254689-4760B946-D33F-4B7C-96EC-F4EC34C9C627Q45759415-EFDEB830-387E-4A0B-A101-4C65A77551F7
P2860
Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Patient-reported neuropathy an ...... ed non-small-cell lung cancer.
@ast
Patient-reported neuropathy an ...... ed non-small-cell lung cancer.
@en
type
label
Patient-reported neuropathy an ...... ed non-small-cell lung cancer.
@ast
Patient-reported neuropathy an ...... ed non-small-cell lung cancer.
@en
prefLabel
Patient-reported neuropathy an ...... ed non-small-cell lung cancer.
@ast
Patient-reported neuropathy an ...... ed non-small-cell lung cancer.
@en
P2093
P1476
Patient-reported neuropathy an ...... ed non-small-cell lung cancer.
@en
P2093
Hiroshi Sakai
Isamu Okamoto
James Orsini
Jeremy K Hon
Mark A Socinski
Markus F Renschler
Ray D Page
Vera Hirsh
P356
10.1097/JTO.0000000000000011
P577
2014-01-01T00:00:00Z